Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human DLL1 ELISA Kit (AC3268)
Cat.#: ASET-1857
Specifications
Description Human DLL1 ELISA Kit allows for the in vitro quantitative determination of human DLL1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2098 Human LCN1 ELISA Kit (AC3509) Quantitative inquiry ASET-1889 Human Toca-1 ELISA Kit (AC3300) Quantitative inquiry ASET-1112 Human Neprilysin-2 ELISA Kit (AC2523) Quantitative inquiry ASET-1182 Human CDK5 ELISA Kit (AC2593) Quantitative inquiry ASET-1570 Human Neurotrophin 3 ELISA Kit (AC2981) Quantitative inquiry ASET-2512 Rat Oxytocin ELISA Kit (AC3923) Quantitative inquiry ASET-1216 Mouse VEGFC ELISA Kit (AC2627) Quantitative inquiry ASET-2139 Rat Neurotensin ELISA Kit (AC3550) Quantitative inquiry ASET-2202 Human Estrogen Receptor beta ELISA Kit (AC3613) Quantitative inquiry ASET-2339 Human Cathepsin B ELISA Kit (AC3750) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket